Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 23.94 million. The enterprise value is 16.67 million.

Market Cap	23.94M
Enterprise Value	16.67M

Important Dates

The last earnings date was Wednesday, April 22, 2026.

Earnings Date	Apr 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 11.34% in one year.

Current Share Class	43.37M
Shares Outstanding	43.37M
Shares Change (YoY)	+11.34%
Shares Change (QoQ)	-3.62%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	n/a
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.31
PB Ratio	1.60
P/TBV Ratio	2.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.78
EV / Sales	0.22
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.02.

Current Ratio	1.43
Quick Ratio	1.33
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-208.53

Financial Efficiency

Return on equity (ROE) is -53.78% and return on invested capital (ROIC) is -33.11%.

Return on Equity (ROE)	-53.78%
Return on Assets (ROA)	-23.48%
Return on Invested Capital (ROIC)	-33.11%
Return on Capital Employed (ROCE)	-61.96%
Weighted Average Cost of Capital (WACC)	7.17%
Revenue Per Employee	8.61M
Profits Per Employee	-1.04M
Employee Count	9
Asset Turnover	3.10
Inventory Turnover	859.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.25% in the last 52 weeks. The beta is 0.52, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-22.25%
50-Day Moving Average	0.61
200-Day Moving Average	0.65
Relative Strength Index (RSI)	42.66
Average Volume (20 Days)	83,518

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 77.45 million and -9.35 million in losses. Loss per share was -0.22.

Revenue	77.45M
Gross Profit	1.41M
Operating Income	-9.38M
Pretax Income	-9.35M
Net Income	-9.35M
EBITDA	-7.09M
EBIT	-9.38M
Loss Per Share	-0.22

Full Income Statement

Balance Sheet

The company has 7.59 million in cash and 320,000 in debt, giving a net cash position of 7.27 million or 0.17 per share.

Cash & Cash Equivalents	7.59M
Total Debt	320,000
Net Cash	7.27M
Net Cash Per Share	0.17
Equity (Book Value)	15.01M
Book Value Per Share	0.35
Working Capital	3.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.29M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 1.82%, with operating and profit margins of -12.12% and -12.08%.

Gross Margin	1.82%
Operating Margin	-12.12%
Pretax Margin	-12.08%
Profit Margin	-12.08%
EBITDA Margin	-9.15%
EBIT Margin	-12.12%
FCF Margin	n/a

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.34%
Shareholder Yield	-11.34%
Earnings Yield	-39.07%
FCF Yield	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of -0.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.25
Piotroski F-Score	n/a